Search research articles
Contact Us
Filters
Showing results (941-950 of 1,366) with videos related to
Page
of 137
Sort By:
ALTEX
|
July 18, 2013
Predictive value of cell assays for developmental toxicity and embryotoxicity of conazole fungicides
Karin Dreisig, Camilla Taxvig, Mia Birkhøj Kjærstad, et al.
ALTEX
|
July 18, 2013
In vitro metabolism and bioavailability tests for endocrine active substances: what is needed next for regulatory purposes?
Miriam N Jacobs, Susan C Laws, Kate Willett, et al.
ALTEX
|
July 18, 2013
Bayesian network integrated testing strategy and beyond
Federico M Stefanini
ALTEX
|
July 18, 2013
Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles
Daniel R Dietrich, Sonja von Aulock, Hans Marquardt, et al.
ALTEX
|
May 14, 2013
Mechanistic validation
Thomas Hartung, Sebastian Hoffmann, Martin Stephens
ALTEX
|
May 14, 2013
Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test
Nina Hasiwa, Mardas Daneshian, Peter Bruegger, et al.
ALTEX
|
May 14, 2013
Alternative in vitro methods to characterize the role of Endocrine Active Substances (EASs) in hormone-targeted tissues
Costanza Rovida, Isabella De Angelis, Stefano Lorenzetti
ALTEX
|
May 14, 2013
Advanced tests for skin and respiratory sensitization assessment
Costanza Rovida, Stefan F Martin, Manon Vivier, et al.
ALTEX
|
July 17, 2014
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology
Natalie Alépée, Anthony Bahinski, Mardas Daneshian, et al.
ALTEX
|
November 1, 2013
Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases
Stefan Schildknecht, Christiaan Karreman, Dominik Pöltl, et al.
Page
of 137
Search research articles
Search
Showing results (941-950 of 1,366) with videos related to
Sort By:
Page
of 137
ALTEX
|
July 18, 2013
Predictive value of cell assays for developmental toxicity and embryotoxicity of conazole fungicides
Karin Dreisig, Camilla Taxvig, Mia Birkhøj Kjærstad, et al.
ALTEX
|
July 18, 2013
In vitro metabolism and bioavailability tests for endocrine active substances: what is needed next for regulatory purposes?
Miriam N Jacobs, Susan C Laws, Kate Willett, et al.
ALTEX
|
July 18, 2013
Bayesian network integrated testing strategy and beyond
Federico M Stefanini
ALTEX
|
July 18, 2013
Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles
Daniel R Dietrich, Sonja von Aulock, Hans Marquardt, et al.
ALTEX
|
May 14, 2013
Mechanistic validation
Thomas Hartung, Sebastian Hoffmann, Martin Stephens
ALTEX
|
May 14, 2013
Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test
Nina Hasiwa, Mardas Daneshian, Peter Bruegger, et al.
ALTEX
|
May 14, 2013
Alternative in vitro methods to characterize the role of Endocrine Active Substances (EASs) in hormone-targeted tissues
Costanza Rovida, Isabella De Angelis, Stefano Lorenzetti
ALTEX
|
May 14, 2013
Advanced tests for skin and respiratory sensitization assessment
Costanza Rovida, Stefan F Martin, Manon Vivier, et al.
ALTEX
|
July 17, 2014
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology
Natalie Alépée, Anthony Bahinski, Mardas Daneshian, et al.
ALTEX
|
November 1, 2013
Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases
Stefan Schildknecht, Christiaan Karreman, Dominik Pöltl, et al.
Page
of 137